Clinical Trials Directory

Trials / Completed

CompletedNCT03234010

CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes

CSD170303: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
122 (actual)
Sponsor
RAI Services Company · Industry
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of four different marketed electronic cigarettes. Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.

Detailed description

This will be a single-center, randomized, open-label, parallel study during which up to 140 healthy adult subjects, consisting of 35 subjects per marketed EC product, will be enrolled. Subjects will be evaluated for plasma nicotine uptake, as well as overall product liking. The study will involve the use of four (4) marketed EC products in tobacco consumers who are exclusive smokers (i.e., naïve EC users) or dual users of cigarettes and ECs (i.e., intermittent EC users).

Conditions

Interventions

TypeNameDescription
OTHERFT21092An electronic cigarette
OTHERFT21093An electronic cigarette
OTHERFT21096An electronic cigarette
OTHERFT21097An electronic cigarette

Timeline

Start date
2017-07-18
Primary completion
2017-09-30
Completion
2017-09-30
First posted
2017-07-31
Last updated
2017-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03234010. Inclusion in this directory is not an endorsement.

CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes (NCT03234010) · Clinical Trials Directory